Back to Search
RYAN RANSOM, MD, PHD
MD, PHD
Neurological Surgery Physician
NPI: 1578172789IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
30921(MN)
CMS Specialties
PrimaryNEUROSURGERY
Education
UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Class of 2020
Research & Publications (20)
2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
PMID 18553956·J Med Chem·2008
7-preclinical
Proline bis-amides as potent dual orexin receptor antagonists.
PMID 18207395·Bioorg Med Chem Lett·2008
7-preclinical
Bradykinin B1 receptor antagonists: an alpha-hydroxy amide with an improved metabolism profile.
PMID 18722115·Bioorg Med Chem Lett·2008
7-preclinical
Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists.
PMID 18061443·Bioorg Med Chem Lett·2008
7-preclinical
A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity.
PMID 18240388·Bioorg Med Chem Lett·2008
7-preclinical
The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?
PMID 18090667·Curr Opin Nephrol Hypertens·2008
6-review
Estimating HIV incidence in voluntary counseling and testing clients in Uganda (1992-2003).
PMID 17075393·J Acquir Immune Defic Syndr·2007
8-other
Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
PMID 17697087·Trop Med Int Health·2007
8-other
Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.
PMID 17228869·J Med Chem·2007
7-preclinical
Identification of the glomerular podocyte as a target for growth hormone action.
PMID 17272398·Endocrinology·2007
7-preclinical
Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.
PMID 17428657·Bioorg Med Chem Lett·2007
7-preclinical
Bradykinin B1 antagonists: biphenyl SAR studies in the cyclopropanecarboxamide series.
PMID 17482459·Bioorg Med Chem Lett·2007
7-preclinical
Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.
PMID 16968909·Am J Trop Med Hyg·2006
7-preclinical
Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda.
PMID 17084759·Lancet·2006
8-other
Single and combination toxic metal exposures induce apoptosis in cultured murine podocytes exclusively via the extrinsic caspase 8 pathway.
PMID 16421179·Toxicol Sci·2006
7-preclinical
Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.
PMID 16480259·J Med Chem·2006
7-preclinical
5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists.
PMID 16529929·Bioorg Med Chem Lett·2006
8-other
Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study.
PMID 16631881·Lancet·2006
8-other
Amphetamine-induced locomotor activity is reduced in mice following MPTP treatment but not following selegiline/MPTP treatment.
PMID 16757017·Pharmacol Biochem Behav·2006
7-preclinical
Identification of the critical residues of bradykinin receptor B1 for interaction with the kinins guided by site-directed mutagenesis and molecular modeling.
PMID 17128974·Biochemistry·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1578172789
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile